COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms.

Overall, our study contributes to the knowledge of COPD management during the COVID-19 Omicron outbreak and emphasizes the importance of considering individual immune profiles to improve care for COPD patients in the face of the ongoing global health crisis.